Page last updated: 2024-10-26

pentetic acid and Cerebrovascular Moyamoya Disease

pentetic acid has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Research Excerpts

ExcerptRelevanceReference
"We report three cases of children with moyamoya disease who revealed prominent leptomeningeal enhancement on postcontrast magnetic resonance (MR) images."1.29Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report. ( Kuroiwa, T; Ohta, T; Tanaka, H, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohta, T1
Tanaka, H1
Kuroiwa, T1
Maeda, T1
Mori, H1
Hisada, K1
Sugino, M1

Other Studies

2 other studies available for pentetic acid and Cerebrovascular Moyamoya Disease

ArticleYear
Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report.
    Neurosurgery, 1995, Volume: 37, Issue:5

    Topics: Brain Ischemia; Cerebral Revascularization; Child; Contrast Media; Diagnosis, Differential; Female;

1995
Radionuclide cerebral angiography in moyamoya disease.
    Clinical nuclear medicine, 1979, Volume: 4, Issue:12

    Topics: Adult; Arterial Occlusive Diseases; Brain; Cerebral Angiography; Female; Follow-Up Studies; Humans;

1979